Bed occupancy rates and hospital-acquired Clostridium difficile infection: A cohort study

Infection Control and Hospital Epidemiology

Volumn 34, Issue 10, 2013, Pages 1062-1069

  Ahyow, Lauren C ^a   Lambert, Paul C ^b,c   Jenkins, David R ^d   Neal, Keith R ^e   Tobin, Martin ^b,f  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL BED UTILIZATION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; WARD;

ADULT; AGED; AGED, 80 AND OVER; BED OCCUPANCY; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84884177959     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/673156     Document Type: Article

References (43)

1. Wilcox MH, Eastwood KA. Evaluation Report: Clostridium difficile Toxin Detection Assays. London: Centre for Evidence-Based Purchasing, 2009.
2. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009;7(7):526-536.
3. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23(3):529-549.
4. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173(9):1037-1042.
5. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009;15(13):1554-1580.
6. Rouphael NG, O'Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 2008;635:e1-e6.
7. Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201-1205.
8. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26(3):273-280.
9. Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12:2-18.
10. Office for National Statistics. Deaths involving Clostridium difficile: England and Wales, 1999 and 2001-06. Health Stat Q 2008: 52-56.
11. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005:1530-1533.
12. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353(23):2433-2441.
13. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41(9):1254-1260.
14. Thomas C, Stevenson M, Riley TV. Antibiotics and hospitalacquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003;51(6):1339-1350.
15. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353(23):2442-2449.
16. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001;357(9251):189-193.
17. Kyne L, Sougioultzis S, McFarland LV, Kelly CF. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002;23(11):653-659.
18. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010;170(9):772-778.
19. Griffiths P, Renz A, Hughes J, Rafferty AM. Impact of organisation and management factors on infection control in hospitals: a scoping review. J Hosp Infect 2009;73(1):1-14.
20. Clements A, Halton K, Graves N, et al. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis 2008;8(7):427-434.
21. Cunningham JB, Kernohan WG, Rush T. Bed occupancy, turnover intervals and MRSA rates in English hospitals. Br J Nurs 2006;15(12):656-660.
22. Cunningham JB, Kernohan WG, Sowney R. Bed occupancy and turnover interval as determinant factors in MRSA infections in acute settings in Northern Ireland: 1 April 2001 to 31 March 2003. J Hosp Infect 2005;61(3):189-193.
23. Kaier K, Luft D, Dettenkofer M, Kist M, Frank U. Correlations between bed occupancy rates and Clostridium difficile infections: a time-series analysis. Epidemiol Infect 2010;139:482-485.
24. Eastwood K, Patrick E, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009;47(10):3211-3217.
25. Department of Health (DH); Health Protection Agency. Clostridium difficile Infection: How to Deal with the Problem. London: DH, 2008.
26. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431-455.
27. Department of Health (DH). Saving Lives: High Impact Intervention No 6: Reducing the Risk of Infection from and the Presence of Clostridium difficile. London: DH, 2006.
28. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Statistics for Biology and Health. London: Springer, 2000.
29. Nijssen S, Bonten MJM, Franklin C, Verhoef J, Hoepelman AIM, Weinstein RA. Relative risk of physicians and nurses to transmit pathogens in a medical intensive care unit. Arch Intern Med 2003;163(22):2785-2786.
30. Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009;73(4):378-385.
31. Pittet D, Mourouga P, Perneger TV; Members of the Infection Control Program. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999;130(2):126-130.
32. Allegranzi B, Pittet D. Role of hand hygiene in healthcareassociated infection prevention. J Hosp Infect 2009;73(4):305-315.
33. Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 2008;8(2):101-113.
34. Cooper BS, Stone SR, Kibbler CC, et al. Systematic review of isolation policies in the hospital management of methicillinresistant Staphylococcus aureus: a review of the literature with epidemiological and economic modeling. Health Technol Assess 2003;7(39):1-194.
35. Casewell MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1995;30:465-471.
36. Department of Health (DH). Hospital Organisation, Speciality Mix and MRSA. London: DH, 2007.
37. Borg MA, Suda D, Scicluna E. Time-series analysis of the impact of bed occupancy rates on the incidence of methicillin-resistant Staphylococcus aureus infection in overcrowded general wards. Infect Control Hosp Epidemiol 2008;29(6):496-502.
38. Department of Health (DH). Hospital Activity Statistics. London: DH, 2009.
39. Duckett S. Australian hospital services: an overview. Aust Health Rev 2002;25:2-18.
40. American Hospital Association (AHA). Annual Survey Data, 2008, for Community Hospitals. Washington, DC: AHA, 2008.
41. Orendi J. Health-care organisation, hospital-bed occupancy, and MRSA. Lancet 2008;371:1401-1402.
42. Clements ACA, Magalhaes RJS, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010;10(6):395-404.
43. Kmietowicz Z. New health secretary warns further NHS efficiency savings may be needed. BMJ 2010;340:c2600.